Rezultaty - Alain Baron
- Rezultaty 1 - 20 Rezultaty od 24
- Idź do następnej strony
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure od Que Liu, Christen M. Anderson, Anatoly Broyde, Clara J. Polizzi, Rayne Fernandez, Alain Baron, David G. Parkes
Wydane 2010Artigo -
15
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials od Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman
Wydane 2016Artigo -
16
Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes od Mark Fineman, Thomas A. Bicsak, Larry Z. Shen, Kristin Taylor, Eling Gaines, Amanda Varns, Dennis Kim, Alain Baron
Wydane 2003Artigo -
17
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea od David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron
Wydane 2005Artigo -
18
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies od John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman
Wydane 2015Artigo -
19
-
20
Narzędzie wyszukiwania:
Podobne hasła
Endocrinology
Internal medicine
Medicine
Diabetes mellitus
Insulin
Type 2 diabetes
Insulin resistance
Exenatide
Alternative medicine
Pathology
Placebo
Gastroenterology
Biology
Obesity
Receptor
Vasodilation
Blood pressure
Endothelial dysfunction
Glycemic
Islet
Metformin
Postprandial
Adverse effect
Amylin
Biochemistry
Chemistry
Endothelin receptor
Endothelium
Gastric emptying
Pharmacology